DNA X PE ratio SONM
Share price divided by earnings per share over the last twelve months, since 2018.
- Today, Oct 23, 2026
- n/m
- losses over the last year
- Earnings per share, 12 months
- −$9.27
- to Jun 30, 2026
- Share price
- $3.08
- Oct 23, 2026
- Peer median
- 11.4×
DNA X has no meaningful PE ratio today: it lost $9.27 a share over the last twelve months, and a PE needs earnings.
It has had no meaningful PE for most of its history, so the chart below shows the earnings per share a PE divides the price by.
Earnings per share over time
A PE divides the share price by these earnings. While they were a loss or a sliver, the PE meant nothing, so this chart shows the earnings themselves.
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$26.10 | n/a |
| FY2024 | −$125.85 | −35058% |
| FY2023 | $0.36 | n/a |
| FY2022 | −$120.60 | n/a |
| FY2021 | −$799.20 | n/a |
| FY2020 | −$1611.00 | n/a |
| FY2019 | −$2466.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.92 | n/a | −$9.27 | |
| Q1 FY26 | $5.01 | +255% | −$22.50 | |
| Q4 FY25 | −$8.53 | n/a | −$26.10 | |
| Q3 FY25 | −$4.83 | n/a | −$97.02 | |
| Q2 FY25 | −$14.15 | n/a | −$101.51 | |
| Q1 FY25 | $1.41 | n/a | −$112.74 | |
| Q4 FY24 | −$79.45 | n/a | −$125.85 | |
| Q3 FY24 | −$9.32 | −531% | −$51.98 | |
| Q2 FY24 | −$25.38 | −1382% | −$40.50 | |
| Q1 FY24 | −$11.70 | −750% | −$13.14 | |
| Q4 FY23 | −$5.58 | n/a | $0.36 | |
| Q3 FY23 | $2.16 | n/a | $0.54 |
Against its peers
Companies in Technology nearest DNA X's size, closest first, today.
| Company | PE ratio |
|---|---|
| SONMDNA X | n/m |
| MSGMMotorsport Games | 11.4× |
| FIEEFiEE | 9.3× |
| NSYSNortech Systems | 27.8× |
| Peer median | 11.4× |
What the PE ratio tells you
Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.
Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.
More on DNA X
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.